Skip to content

Efficacy and Safety of Glucose-Containing Dialysate in Hemodialysis Patients

Efficacy and Safety of Glucose-Containing Dialysate in Hemodialysis Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125394
Enrollment
Unknown
Registered
2026-05-26
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis

Interventions

Group A:Glucose-containing dialysis followed by glucose-free dialysis
Group B:Glucose-free dialysis followed by glucose-containing dialysis

Sponsors

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years, regardless of gender; 2. On regular hemodialysis for more than 3 months; 3. Receiving dialysis three times per week.

Exclusion criteria

Exclusion criteria: 1. Patients with other severe diseases, such as malignant tumors, severe liver dysfunction (ALT or AST > 2.5×ULN), gastrointestinal bleeding, severe primary diseases of the hematopoietic system, or severe hypertension (systolic blood pressure >=200 mmHg, diastolic blood pressure >=120 mmHg) with poorly controlled blood pressure; 2. Those who have experienced acute cardiovascular or cerebrovascular events within the past 3 months, including acute coronary syndrome, cerebrovascular accident, or congestive heart failure, or those requiring hospitalization due to systemic infectious diseases or decompensated diabetes; 3. With expected survival time of less than 1 year; 4. Planned kidney transplantation within 1 year.

Design outcomes

Primary

MeasureTime frame
Glycemic Variability (GV);

Secondary

MeasureTime frame
Heart Rate Variability (HRV);Adverse event incidence rate;

Countries

China

Contacts

Public ContactZhou Jianfang

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University

ccychen97@163.com+86 133 7255 8962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026